2017
DOI: 10.1002/tre.580
|View full text |Cite
|
Sign up to set email alerts
|

Surgery in metastatic prostate cancer: a pilot study

Abstract: There is some evidence to suggest that radical treatment of the primary tumour in patients diagnosed with metastatic prostate cancer can reduce symptomatic progression and increase survival. In this article, the author describes a pilot study to investigate whether a large study looking at survival benefit in early metastatic disease is feasible in the UK and calls for recruits.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…No robust evidence is currently available regarding surgery + ADT in patients with de novo oligometastatic PCa. Results from the studies that involve the comparison of RP + ADT and ADT alone, for example, SWOG 1802 (trial identifier: NCT03678025) and TRoMbone, 77 are awaited. In patients with de novo locally advanced disease with regional nodal involvement, ADT + local therapy ( RT or surgery ) could improve the disease control . …”
Section: Resultsmentioning
confidence: 99%
“…No robust evidence is currently available regarding surgery + ADT in patients with de novo oligometastatic PCa. Results from the studies that involve the comparison of RP + ADT and ADT alone, for example, SWOG 1802 (trial identifier: NCT03678025) and TRoMbone, 77 are awaited. In patients with de novo locally advanced disease with regional nodal involvement, ADT + local therapy ( RT or surgery ) could improve the disease control . …”
Section: Resultsmentioning
confidence: 99%